Wolverine Asset Management LLC Increases Stock Holdings in BlackRock Health Sciences Term Trust $BMEZ

Wolverine Asset Management LLC raised its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZFree Report) by 78.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 401,511 shares of the company’s stock after purchasing an additional 176,993 shares during the period. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $6,043,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Bank of America Corp DE increased its stake in BlackRock Health Sciences Term Trust by 4.1% in the third quarter. Bank of America Corp DE now owns 1,535,091 shares of the company’s stock valued at $22,136,000 after purchasing an additional 61,105 shares during the last quarter. Penserra Capital Management LLC increased its stake in BlackRock Health Sciences Term Trust by 15.2% in the third quarter. Penserra Capital Management LLC now owns 1,332,633 shares of the company’s stock valued at $19,216,000 after purchasing an additional 175,629 shares during the last quarter. Invesco Ltd. increased its stake in BlackRock Health Sciences Term Trust by 42.7% in the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock valued at $13,398,000 after purchasing an additional 278,024 shares during the last quarter. Readystate Asset Management LP increased its stake in BlackRock Health Sciences Term Trust by 664.6% in the third quarter. Readystate Asset Management LP now owns 247,074 shares of the company’s stock valued at $3,563,000 after purchasing an additional 214,761 shares during the last quarter. Finally, Shaker Financial Services LLC purchased a new position in BlackRock Health Sciences Term Trust in the third quarter valued at approximately $2,654,000.

BlackRock Health Sciences Term Trust Trading Up 0.1%

Shares of BlackRock Health Sciences Term Trust stock opened at $14.10 on Monday. BlackRock Health Sciences Term Trust has a 52 week low of $13.67 and a 52 week high of $15.80. The firm’s 50 day moving average is $14.39 and its two-hundred day moving average is $14.87.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be given a dividend of $0.11 per share. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 9.4%.

About BlackRock Health Sciences Term Trust

(Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.

Further Reading

Institutional Ownership by Quarter for BlackRock Health Sciences Term Trust (NYSE:BMEZ)

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.